BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 34989902)

  • 1. Metabolite profiling reveals a connection between aldehyde dehydrogenase 1A3 and GABA metabolism in breast cancer metastasis.
    Dahn ML; Walsh HR; Dean CA; Giacomantonio MA; Fernando W; Murphy JP; Walker OL; Wasson MD; Gujar S; Pinto DM; Marcato P
    Metabolomics; 2022 Jan; 18(1):9. PubMed ID: 34989902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aldehyde dehydrogenase 1A3 influences breast cancer progression via differential retinoic acid signaling.
    Marcato P; Dean CA; Liu RZ; Coyle KM; Bydoun M; Wallace M; Clements D; Turner C; Mathenge EG; Gujar SA; Giacomantonio CA; Mackey JR; Godbout R; Lee PW
    Mol Oncol; 2015 Jan; 9(1):17-31. PubMed ID: 25106087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Citral reduces breast tumor growth by inhibiting the cancer stem cell marker ALDH1A3.
    Thomas ML; de Antueno R; Coyle KM; Sultan M; Cruickshank BM; Giacomantonio MA; Giacomantonio CA; Duncan R; Marcato P
    Mol Oncol; 2016 Nov; 10(9):1485-1496. PubMed ID: 27592281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer subtype dictates DNA methylation and ALDH1A3-mediated expression of tumor suppressor RARRES1.
    Coyle KM; Murphy JP; Vidovic D; Vaghar-Kashani A; Dean CA; Sultan M; Clements D; Wallace M; Thomas ML; Hundert A; Giacomantonio CA; Helyer L; Gujar SA; Lee PW; Weaver IC; Marcato P
    Oncotarget; 2016 Jul; 7(28):44096-44112. PubMed ID: 27286452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ALDH1A3-regulated long non-coding RNA NRAD1 is a potential novel target for triple-negative breast tumors and cancer stem cells.
    Vidovic D; Huynh TT; Konda P; Dean C; Cruickshank BM; Sultan M; Coyle KM; Gujar S; Marcato P
    Cell Death Differ; 2020 Jan; 27(1):363-378. PubMed ID: 31197235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis.
    Marcato P; Dean CA; Pan D; Araslanova R; Gillis M; Joshi M; Helyer L; Pan L; Leidal A; Gujar S; Giacomantonio CA; Lee PW
    Stem Cells; 2011 Jan; 29(1):32-45. PubMed ID: 21280157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Essential role of aldehyde dehydrogenase 1A3 for the maintenance of non-small cell lung cancer stem cells is associated with the STAT3 pathway.
    Shao C; Sullivan JP; Girard L; Augustyn A; Yenerall P; Rodriguez-Canales J; Liu H; Behrens C; Shay JW; Wistuba II; Minna JD
    Clin Cancer Res; 2014 Aug; 20(15):4154-66. PubMed ID: 24907115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential Functional Roles of ALDH1A1 and ALDH1A3 in Mediating Metastatic Behavior and Therapy Resistance of Human Breast Cancer Cells.
    Croker AK; Rodriguez-Torres M; Xia Y; Pardhan S; Leong HS; Lewis JD; Allan AL
    Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28937653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of ALDH1A3 as a Viable Therapeutic Target in Breast Cancer Metastasis-Initiating Cells.
    Yamashita D; Minata M; Ibrahim AN; Yamaguchi S; Coviello V; Bernstock JD; Harada S; Cerione RA; Tannous BA; La Motta C; Nakano I
    Mol Cancer Ther; 2020 May; 19(5):1134-1147. PubMed ID: 32127468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ALDH1A3-mTOR axis as a therapeutic target for anticancer drug-tolerant persister cells in gastric cancer.
    Kawakami R; Mashima T; Kawata N; Kumagai K; Migita T; Sano T; Mizunuma N; Yamaguchi K; Seimiya H
    Cancer Sci; 2020 Mar; 111(3):962-973. PubMed ID: 31960523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical implications of ALDH1A1 and ALDH1A3 mRNA expression in melanoma subtypes.
    Samson JM; Ravindran Menon D; Smith DE; Baird E; Kitano T; Gao D; Tan AC; Fujita M
    Chem Biol Interact; 2019 Dec; 314():108822. PubMed ID: 31580832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of breast cancer growth via miR-7 suppressing ALDH1A3 activity concomitant with decreasing breast cancer stem cell subpopulation.
    Pan M; Li M; You C; Zhao F; Guo M; Xu H; Li L; Wang L; Dou J
    J Cell Physiol; 2020 Feb; 235(2):1405-1416. PubMed ID: 31347176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3.
    Mao P; Joshi K; Li J; Kim SH; Li P; Santana-Santos L; Luthra S; Chandran UR; Benos PV; Smith L; Wang M; Hu B; Cheng SY; Sobol RW; Nakano I
    Proc Natl Acad Sci U S A; 2013 May; 110(21):8644-9. PubMed ID: 23650391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ALDH1A3 promotes invasion and metastasis in triple-negative breast cancer by regulating the plasminogen activation pathway.
    Bharadwaj AG; McLean ME; Dahn ML; Cahill HF; Wasson MD; Arun RP; Walker OL; Cruickshank BM; Fernando W; Venkatesh J; Barnes PJ; Bethune G; Knapp G; Helyer LK; Giacomantonio CA; Waisman DM; Marcato P
    Mol Oncol; 2024 Jan; 18(1):91-112. PubMed ID: 37753740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An aldehyde dehydrogenase 1A3 inhibitor attenuates the metastasis of human colorectal cancer.
    Duan JJ; Wang D; Cai J; Chen JJ; Zheng XX; Chen TQ; Wang J; Zhang X; Yang QK; Yu SC
    Cancer Lett; 2022 Jun; 536():215662. PubMed ID: 35331786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldehyde dehydrogenase activity plays a Key role in the aggressive phenotype of neuroblastoma.
    Flahaut M; Jauquier N; Chevalier N; Nardou K; Balmas Bourloud K; Joseph JM; Barras D; Widmann C; Gross N; Renella R; Mühlethaler-Mottet A
    BMC Cancer; 2016 Oct; 16(1):781. PubMed ID: 27724856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The stem cell/cancer stem cell marker ALDH1A3 regulates the expression of the survival factor tissue transglutaminase, in mesenchymal glioma stem cells.
    Sullivan KE; Rojas K; Cerione RA; Nakano I; Wilson KF
    Oncotarget; 2017 Apr; 8(14):22325-22343. PubMed ID: 28423611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profiling of the transcriptional response to all-trans retinoic acid in breast cancer cells reveals RARE-independent mechanisms of gene expression.
    Coyle KM; Maxwell S; Thomas ML; Marcato P
    Sci Rep; 2017 Nov; 7(1):16684. PubMed ID: 29192143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of ALDH1A3 might independently influence poor progression-free and overall survival in patients with glioma via maintaining glucose uptake and lactate production.
    Ni W; Xia Y; Luo L; Wen F; Hu D; Bi Y; Qi J
    Cell Biol Int; 2020 Feb; 44(2):569-582. PubMed ID: 31642564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aldehyde dehydrogenase 1A3 (ALDH1A3) is regulated by autophagy in human glioblastoma cells.
    Wu W; Schecker J; Würstle S; Schneider F; Schönfelder M; Schlegel J
    Cancer Lett; 2018 Mar; 417():112-123. PubMed ID: 29306018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.